Oaktree Acquisition Corp. III Life Sciences is a blank check company, which was created for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. The company is headquartered in Los Angeles, California. The company went IPO on 2024-10-24. The firm is formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses or entities.
How did OACC's recent EPS compare to expectations?
The most recent EPS for Oaktree Acquisition III Life Sciences Corp is $, expectations of $.
How did Oaktree Acquisition III Life Sciences Corp OACC's revenue perform in the last quarter?
Oaktree Acquisition III Life Sciences Corp revenue for the last quarter is $
What is the revenue estimate for Oaktree Acquisition III Life Sciences Corp?
According to of Wall street analyst, the revenue estimate of Oaktree Acquisition III Life Sciences Corp range from $ to $
What's the earning quality score for Oaktree Acquisition III Life Sciences Corp?
Oaktree Acquisition III Life Sciences Corp has a earning quality score of B+/57.434387. The score is based on a four dimension of Profitability, Growth, Cash generation & Capital Allocation, and Leverage.
When does Oaktree Acquisition III Life Sciences Corp report earnings?
Oaktree Acquisition III Life Sciences Corp next earnings report is expected in 2026-08-11
What are Oaktree Acquisition III Life Sciences Corp's expected earnings?
Oaktree Acquisition III Life Sciences Corp expected earnings is $, according to wall-street analysts.
Did Oaktree Acquisition III Life Sciences Corp beat earnings expectations?
Oaktree Acquisition III Life Sciences Corp recent earnings of $ expectations.